Nicholas K. Foreman

Hematology | Oncology

1811 Plaza Dr
Highlands Ranch, CO 80129

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 161 publications

Molecular Biology and Phase 1 Study of GM-CSF and Intrathecal Trastuzumab in Children with Recurrent Posterior Fossa Ependymoma.

Molecular Biology and Phase 1 Study of GM-CSF and Intrathecal Trastuzumab in Children with Recurrent Posterior Fossa Ependymoma.

Journal: Neuro-oncology

Published: October 26, 2025

Molecular biology and phase 1 study of GM-CSF and intrathecal trastuzumab in children with recurrent -posterior fossa ependymoma.

Molecular biology and phase 1 study of GM-CSF and intrathecal trastuzumab in children with recurrent -posterior fossa ependymoma.

Journal: Neuro-oncology

Published: October 26, 2025

Differential phagocytosis induces diverse macrophage activation states in malignant gliomas.

Differential phagocytosis induces diverse macrophage activation states in malignant gliomas.

Journal: Journal for immunotherapy of cancer

Published: August 24, 2025

A cycling, progenitor-like cell population at the base of atypical teratoid rhabdoid tumor subtype differentiation trajectories.

A cycling, progenitor-like cell population at the base of atypical teratoid rhabdoid tumor subtype differentiation trajectories.

Journal: Neuro-oncology

Published: July 29, 2025

Targeting processive transcription for Myc-driven circuitry in medulloblastoma.

Targeting processive transcription for Myc-driven circuitry in medulloblastoma.

Journal: Neuro-oncology

Published: May 15, 2025

Phase 3 randomized trial of postirradiation chemotherapy in patients with newly diagnosed ependymoma: A report from the Children's Oncology Group.

Phase 3 randomized trial of postirradiation chemotherapy in patients with newly diagnosed ependymoma: A report from the Children's Oncology Group.

Journal: Neuro-oncology

Published: April 17, 2025

Targeting processive transcription for Myc-driven circuitry in medulloblastoma.

Targeting processive transcription for Myc-driven circuitry in medulloblastoma.

Journal: bioRxiv : the preprint server for biology

Published: April 01, 2025

Differential Phagocytosis induces Diverse Macrophage Activation States in Malignant Gliomas.

Differential Phagocytosis induces Diverse Macrophage Activation States in Malignant Gliomas.

Journal: bioRxiv : the preprint server for biology

Published: April 01, 2025

Loss of LDOC1 by chromatin compaction in mesenchymal tumor cells is required for PFA1 ependymoma growth.

Loss of LDOC1 by chromatin compaction in mesenchymal tumor cells is required for PFA1 ependymoma growth.

Journal: Neuro-oncology

Published: February 04, 2025

A cycling, progenitor-like cell population at the base of atypical teratoid rhabdoid tumor subtype differentiation trajectories.

A cycling, progenitor-like cell population at the base of atypical teratoid rhabdoid tumor subtype differentiation trajectories.

Journal: Neuro-oncology

Published: January 13, 2025

Single-cell multi-omics identifies metabolism-linked epigenetic reprogramming as a driver of therapy-resistant medulloblastoma.

Single-cell multi-omics identifies metabolism-linked epigenetic reprogramming as a driver of therapy-resistant medulloblastoma.

Journal: Nature communications

Published: December 02, 2024

ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma.

ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: November 08, 2024

Showing 1-12 of 161

Last Updated: 09/26/2026